Kauppinen M T, Saikku P, Kujala P, Herva E, Syrjälä H
Department in Oulu, National Public Health Institute, Finland.
Thorax. 1996 Feb;51(2):185-9. doi: 10.1136/thx.51.2.185.
The importance of Chlamydia pneumoniae as a cause of pneumonia has remained controversial. The clinical picture of C pneumoniae and Streptococcus pneumoniae in patients admitted to hospital with community-acquired pneumonia was compared during a C pneumoniae epidemic in Finland.
Group I consisted of 24 patients in whom serological testing and bacterial culture indicated an association with C pneumoniae only, group II comprised nine patients with both C pneumoniae and S pneumoniae, and group III consisted of 13 patients with S pneumoniae only.
The patients with C pneumoniae suffered from headache more frequently than the other patients (group I, 46%; group II, 11%; and group III, 15%) and had received antimicrobial treatment more often before admission to hospital (group I, 54%; groups II and III, 0%). The patients with C pneumoniae produced few good sputum samples and had suffered from respiratory symptoms longer than those with S pneumoniae (group I, 10 days; groups II and III, 4 days). C reactive protein values on admission were lowest in group I and highest in group II. The antimicrobial treatment provided in hospital covered C pneumoniae in 36% of cases in group I and 0% in group II, while S pneumoniae was covered in all patients. C pneumoniae and S pneumoniae together were associated with more severe disease and a longer stay in hospital.
Pneumonia caused by C pneumoniae was milder but clinically resembled that caused by S pneumoniae, and required hospital treatment even among young patients. Mixed infections were common and should be taken into account when planning antimicrobial treatment for community-acquired pneumonia. Further studies with more patients are needed to evaluate the severity of C pneumoniae pneumonia.
肺炎衣原体作为肺炎病因的重要性一直存在争议。在芬兰肺炎衣原体流行期间,对因社区获得性肺炎入院的患者中肺炎衣原体和肺炎链球菌的临床表现进行了比较。
第一组由24例患者组成,血清学检测和细菌培养仅表明与肺炎衣原体有关;第二组包括9例同时感染肺炎衣原体和肺炎链球菌的患者;第三组由13例仅感染肺炎链球菌的患者组成。
肺炎衣原体感染患者比其他患者更频繁地出现头痛(第一组为46%;第二组为11%;第三组为15%),且在入院前接受抗菌治疗的频率更高(第一组为54%;第二组和第三组为0%)。肺炎衣原体感染患者咳出的合格痰标本较少,呼吸道症状持续时间比肺炎链球菌感染患者更长(第一组为10天;第二组和第三组为4天)。入院时C反应蛋白值在第一组最低,在第二组最高。医院提供的抗菌治疗在第一组36%的病例中覆盖了肺炎衣原体,在第二组为0%,而所有患者的肺炎链球菌均得到了覆盖。肺炎衣原体和肺炎链球菌共同感染与更严重的疾病和更长的住院时间相关。
肺炎衣原体引起的肺炎病情较轻,但临床症状与肺炎链球菌引起的肺炎相似,即使是年轻患者也需要住院治疗。混合感染很常见,在规划社区获得性肺炎的抗菌治疗时应予以考虑。需要对更多患者进行进一步研究以评估肺炎衣原体肺炎的严重程度。